Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Maria A, Lopez Olivo"'
Autor:
Joseph Astorino Nicola, M. Muska Nataliansyah, Maria A. Lopez-Olivo, Adebola Adegboyega, Kelly A. Hirko, Lou-Anne R. Chichester, Nora L. Nock, Pamela Ginex, Shannon M. Christy, Paul Levett
Publikováno v:
Implementation Science Communications, Vol 5, Iss 1, Pp 1-14 (2024)
Abstract Background Champions are integral across research in cancer, yet studies exploring their roles are limited and have produced mixed results. The current review examines and synthesizes descriptions of how champions emerged and the types of ac
Externí odkaz:
https://doaj.org/article/c72821c9fe51403b8be76dfa9deee06c
Autor:
Maria A Lopez-Olivo, Maria E Suarez-Almazor, Gabrielle F Duhon, McKenna Cherry, Huifang Lu, Cassandra Calabrese, Mehmet Altan, Hussain Tawbi, Alexa Meara, Clifton O Bingham, Adi Diab, Viola B Leal, Robert J Volk
Publikováno v:
JMIR Cancer, Vol 10, p e53443 (2024)
BackgroundPatients with cancer and an underlying autoimmune disease who are considering immune checkpoint blockers (ICBs) need to know about the benefits and risks of severe immune-related adverse events and flares of the autoimmune condition. Objec
Externí odkaz:
https://doaj.org/article/f8ca7fd98712473cbeb9c829d394a4e5
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 6, Iss 2, Pp 103-110 (2023)
Introduction: Immune checkpoint inhibitors (ICIs) can cause inflammatory and immune-related adverse events (irAEs) that might worsen the course of COVID-19. We conducted a systematic review (PROSPERO ID: CRD42022307545) to evaluate the clinical cours
Externí odkaz:
https://doaj.org/article/b99cf3be836548e296b05d81c0830c60
Autor:
Pankti Reid, Sabina Sandigursky, Juhee Song, Maria A. Lopez-Olivo, Houssein Safa, Samuel Cytryn, Elizaveta Efuni, Maryam Buni, Anna Pavlick, Michelle Krogsgaard, Osama Abu-Shawer, Mehmet Altan, Jeffrey S. Weber, Osama E. Rahma, Maria E. Suarez-Almazor, Adi Diab, Noha Abdel-Wahab
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTPatients with preexisting autoimmune disease (pAID) are generally excluded from clinical trials for immune checkpoint inhibitors (ICIs) for cancer due to concern of flaring pAID. In this multi-center, retrospective observational study, we com
Externí odkaz:
https://doaj.org/article/e9e4bf95dfc442469304d1d2730ac304
Autor:
Cassandra Calabrese, Maria E Suarez-Almazor, Robert J Volk, Adi Diab, Mehmet Altan, Viola B Leal, Maria A Lopez-Olivo, Gabrielle F Duhon, McKenna Erck, Hussain Tawbi, Alexa Meara, Clifton Bingham
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/4a2a4a71e9834a0d914be351629d575c
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 11, Iss , Pp 100317- (2023)
Objectives: Machine learning algorithms are being increasingly used for predicting hospital readmissions. This meta-analysis evaluated the performance of logistic regression (LR) and machine learning (ML) models for the prediction of 30-day hospital
Externí odkaz:
https://doaj.org/article/af73eb14aeb1465a8ced1dbd2a70b4f4
Autor:
Naomi Q. P. Tan, Shawn P. E. Nishi, Lisa M. Lowenstein, Tito R. Mendoza, Maria A. Lopez‐Olivo, Laura C. Crocker, Karen R. Sepucha, Robert J. Volk
Publikováno v:
Cancer Medicine, Vol 11, Iss 3, Pp 790-797 (2022)
Abstract Background Professional organizations recommend the use of shared decision‐making (SDM) in supporting patients’ decisions about lung cancer screening (LCS). The objective of this study was to assess the impact of the SDM process on patie
Externí odkaz:
https://doaj.org/article/3f1dae9fcf5b4ea294ad6f65bd296d1b
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 2 (2023)
Background Immune checkpoint inhibitors (ICI) can cause off-target inflammatory and immune-related adverse events (irAE). Conceivably, COVID-19 vaccination could trigger an inflammatory and immune response that could induce or aggravate irAE.Methods
Externí odkaz:
https://doaj.org/article/9039d937afb34dfa9b1f1a541cef0575
Autor:
Lama H. Nazer, PharmD, FCCM, Maria A. Lopez-Olivo, MD, PhD, Anne Rain Brown, PharmD, FCCM, John A. Cuenca, MD, Michael Sirimaturos, PharmD, FCCM, Khader Habash, PharmD, Nada AlQadheeb, PharmD, Heather May, PharmD, Victoria Milano, PharmD, Amy Taylor, Joseph L. Nates, MD, MBA, MCCM
Publikováno v:
Critical Care Explorations, Vol 4, Iss 9, p e0757 (2022)
OBJECTIVES:. The reported mortality rates of cancer patients admitted to ICUs vary widely. In addition, there are no studies that examined the outcomes of critically ill cancer patients based on the geographical regions. Therefore, we aimed to evalua
Externí odkaz:
https://doaj.org/article/cb7f491e78da44fdbeb7d4f092b6bdeb
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
We reviewed the available information on the use of immune checkpoint inhibitors (ICIs) in populations with special conditions, namely, patients with HIV, tuberculosis, or underlying autoimmune disease. Available data show that treatment with ICIs is
Externí odkaz:
https://doaj.org/article/1b8d1e5699ce4d34960e3bd4892aa839